ТЭЛА
.pdf
Таблица 9. Профилактика венозных тромбоэмболий (ACCP, 2008).
Группа риска |
Рекомендуемая профилактика |
|
Низкий риск |
Ранняя и «агрессивная» активизация |
|
|
|
|
Умеренный риск |
НФГ 5000 ед п/к 2–3 раза |
|
НМГ (п/к 1 раз эноксапарин 20 мг) |
||
|
||
|
фондапаринукс 2.5 мг п/к 1 раз |
|
|
|
|
Высокий риск |
НМГ (п/к 1 раз эноксапарин 40 мг) |
|
фондапаринукс 2.5 мг п/к 1 раз |
||
|
||
|
варфарин (МНО=2.0–3.0) |
|
|
|
|
Умеренный или высокий риск |
Механическая профилактика эластическими чулками, |
|
ТЭЛА + |
помпой для ступней или ППК |
|
высокий риск кровотечений |
||
|
Примечание. НФГ – нефракционированный гепарин, НМГ – низкомолекулярный гепарин, ППК – перемежающаяся пневматическая компрессия.
ЛИТЕРАТУРА
Лечение оральными антикоагулянтами: Рекомендации Всероссийской ассоциации по изучению тромбозов, геморрагий и патологии сосудов.
М.; 2002. 14 c.
Alikhan R, Cohen AT. Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction). Cochrane Database of Systematic Reviews 2009, Issue 3.
American College of Physicians and the American Academy of Family Physicians. Management of Venous Thromboembolism. Ann Intern Med. 2007; 146: 204–10.
Ansell J, Hirsh J, Hylek E et al. Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians EvidenceBased Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 160S198.
Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 8th ed. 2007.
British Committee for Standards in Haematology. Guidelines on use of vena cava filters. British Journal of Haematology. 2006; 134: 590–5
European Society of Cardiology. Guidelines on the diagnosis and management of acute pulmonary embolism. Europ Heart J. 2008; 29: 2276– 315.
21
Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence–Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133: 381S–453S.
Institute for Clinical Systems Improvement (ICSI). Venous thromboembolism. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007 Jun. 91 p.
Institute for Clinical Systems Improvement (ICSI). Venous thromboembolism prophylaxis. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2008 Oct. 37 p.
Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evi- dence–Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133: 454S–545S.
Tapson V.F. Acute Pulmonary Embolism. New Engl J Med. 2008; 358: 1037–52.
Vardi M., Zittan E., Bitterman H. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism. Cochrane Database of Systematic Reviews 2009, Issue 4.
Young T, Aukes J, Hughes R, Tang H. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database of Systematic Reviews 2007, Issue 4.
22